Lyophilized Drugs - Lyophilization (Freeze-Drying) in the Pharmaceutical Industry, Market Is Expected to Reach US$ 560.2 Billion at a 7.1% CAGR By 2026

Global Lyophilized Drugs Market - Insights

To keep some unstable bulk ingredients stable, lyophilization of the sterile injectable is needed. Lyophilization extends the molecule's shelf life from two to five years. Bulk medicines can also be easily transported thanks to lyophilization. Furthermore, lyophilized medications may be kept at room temperature. Manufacturers such as BUCHI Labortechnik AG, SP Scientific, and West Pharmaceutical Services, Inc. are concentrating on improving the lyophilization process to increase lyophilized drug production ability.

Furthermore, pharmaceutical companies are concentrating on the production of technologically advanced lyophilized drug delivery systems in order to solve or overcome significant obstacles such as multistep drug administration procedures, the inconvenience of self-injection, the possibility of needle stick injuries, and others (lengthy dose preparation timings).

Get Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-pdf/2930

In 2018, the global lyophilized drugs market was projected to be worth US$ 322.9 billion, with a CAGR of 7.1 percent predicted for the forecast period (2018–2026).

The global lyophilized drugs market is expected to expand as regulatory approvals for lyophilized drugs increase:

Increasing regulatory approvals for wide scope of lyophilized formulations for different disease conditions is expected to drive development of lyophilized drugs market. For example, in April 2014, GlaxoSmithKline plc got the U.S. Food and Drug Administration (FDA) endorsement for its Tanzeum (albiglutide lyophilized for infusion), for subcutaneous use, as a once-week after week treatment for type 2 diabetes. In addition, in September 2014, the U.S. Food and Drug Administration (FDA) affirmed another plan of Abilify Maintena (aripiprazole) for expanded delivery injectable suspension, a pre-filled double chamber needle, created by Otsuka Pharmaceutical Development and Commercialization, Inc. The drug is indicated for the treatment of schizophrenia in grown-ups and in support immunotherapy treatment of bipolar I issue in grown-ups.

Furthermore, the lyophilized drugs market is expected to expand significantly due to growing initiatives such as acquisitions by key players for advancement and delivery of anesthetics to various healthcare providing organizations. For example, in December 2018, North American Partners in Anesthesia (NAPA), a single-specialty perioperative and anesthesia management firm in the U.S., gained certain resources of Aisthesis Partners in sedation care and its associated clinical practices ('Aisthesis'). Aisthesis gives its sedation administrations to 25 walking careful focuses (ASCs), 3 clinics, and 3 doctor workplaces across four states in the U.S. furthermore, the District of Columbia. Subsequently, this initiative may add to increasing demand for the lyophilized anesthetics drug, which thus is expected to show huge market development.

Tailored Information as per niche requirement:

LIMITED TIME OFFER - Hurry Up!

Exclusive offer!!! Purchase the report at a discounted rate!!!

Get Discount For Buyers UPTO 30% OFF On Any Research Report

Buy Now with Discount for Premium Report 2021: https://www.coherentmarketinsights.com/promo/buynow/2930

Restraints:

Because of the growing number of product recalls for lyophilized drugs and packaging types, the demand for lyophilized drugs could be hampered. The US Food and Drug Administration (FDA) released a product recall notice in January 2019 for three lots of Vecuronium Bromide for Injection, 10 mg (lyophilized powder) and one lot of Vecuronium Bromide for Injection, 20 mg (lyophilized powder) produced by Sun Pharmaceutical Industries. Due to the presence of glass particulate in the substance, it has been recalled.

Regional Analysis:

North America is expected to observe worthwhile development in the worldwide lyophilized drugs market, inferable from raising occurrence of diseases in the U.S. Presence of significant makers like Fresenius Kabi, Merck and Co. Inc., and Amneal Pharmaceutical who are widely occupied with assembling of lyophilized injectable is adding to development of the North America Lyophilized Drugs Market. In addition, increasing product approvals by regulatory authorities in North America is expected to reinforce development of North America Lyophilized Drugs Market. For example, in December 2015, Aurobindo Pharma Limited got the U.S. FDA approval to make and market Methylprednisolone Sodium Succinate Injection USP (lyophilized medication), 40 mg/vial, 125 mg/vial, 500 mg/vial, and 2 g/vial.

Due to initiatives by key players to expand their production facilities in order to produce lyophilized drugs on a large scale, Asia Pacific is expected to drive growth of the global lyophilized drugs market. For example, Alembic Pharmaceuticals, a company based in India, opened a new manufacturing facility in Panelav, Gujarat, in July 2017. The new facility will produce about 20 million vials of liquid injectable and lyophilized concentrations each year.

Because of ongoing advances in lyophilization processes and an increase in the number of lyophilized drug releases, Europe is expected to expand. BÜCHI Labortechnik AG, for example, launched the Lyovapor platform for freeze drying in April 2017. (lyophilization). Continuous sublimation is a function of the new product.

View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/lyophilized-drugs-market-to-surpass-us-5602-billion-by-2026-1754

Table of Contents

1. Research Objective and Assumption
• Research Objectives
• Assumptions
• Abbreviations
2. Market Overview
• Report Description
• Market Definition and Scope
• Executive Summary
• Market Snippet, By Drug Class
• Market Snippet, By Indication
• Market Snippet, By Packaging Type
• Market Snippet, By Region
• Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
• Market Dynamics
• Drivers
• Restraints
• Market Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Technology Advancements
• Historical Overview
• Merger and Acquisition
• Regulatory Scenario
• PORTER’S Five Forces
• PEST Analysis
4. Global Lyophilized Drugs Market, By Drug Class, 2016 – 2026, (US$ Million)
• Introduction
• Market Share Analysis, 2018 and 2026 (%)
• Y-o-Y Growth Analysis, 2017 – 2026
• Segment Trends
• Anti-infective
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
• Antineoplastic
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
• Diuretics
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
• Proton Pump Inhibitor
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
• Anesthetic
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
• Anticoagulant
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
• NSAID’s
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
• Others
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
5. Global Lyophilized Drugs Market, By Indication, 2016 – 2026, (US$ Million)
• Introduction
• Market Share Analysis, 2018 and 2026 (%)
• Y-o-Y Growth Analysis, 2017 – 2026
• Segment Trends
• Infectious Disease
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
• Autoimmune Disease
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
• Gastrointestinal Disease
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
• Cancer
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
• Others
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
6. Global Lyophilized Drugs Market, By Packaging Type, 2016 – 2026, (US$ Million)
• Introduction
• Market Share Analysis, 2018 and 2026 (%)
• Y-o-Y Growth Analysis, 2017 – 2026
• Segment Trends
• Vials
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
• Syringes
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
• Cartridge
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
7. Global Lyophilized Drugs Market, By Region, 2016 – 2026, (US$ Million)
• Introduction
• Market Share Analysis, By Region, 2018 and 2026 (%)
• Y-o-Y Growth Analysis, By Region, 2017 – 2026
• Regional Trends
• North America
• Market Size and Forecast, By Drug Class, 2016 – 2026, (US$ Million)
• Market Size and Forecast, By Indication, 2016 – 2026, (US$ Million)
• Market Size and Forecast, By Packaging Type, 2016 – 2026, (US$ Million)
• Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
• U.S.
• Canada
• Europe
• Market Size and Forecast, By Drug Class, 2016 – 2026, (US$ Million)
• Market Size and Forecast, By Indication, 2016 – 2026, (US$ Million)
• Market Size and Forecast, By Packaging Type, 2016 – 2026, (US$ Million)
• Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• Market Size and Forecast, By Drug Class, 2016 – 2026, (US$ Million)
• Market Size and Forecast, By Indication, 2016 – 2026, (US$ Million)
• Market Size and Forecast, By Packaging Type, 2016 – 2026, (US$ Million)
• Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
• China
• Japan
• India
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
• Market Size and Forecast, By Drug Class, 2016 – 2026, (US$ Million)
• Market Size and Forecast, By Indication, 2016 – 2026, (US$ Million)
• Market Size and Forecast, By Packaging Type, 2016 – 2026, (US$ Million)
• Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East
• Market Size and Forecast, By Drug Class, 2016 – 2026, (US$ Million)
• Market Size and Forecast, By Indication, 2016 – 2026, (US$ Million)
• Market Size and Forecast, By Packaging Type, 2016 – 2026, (US$ Million)
• Market Size and Forecast, By Country/Region, 2016 – 2026, (US$ Million)
• GCC Countries
• Israel
• Rest of Middle East
• Africa
• Market Size and Forecast, By Drug Class, 2016 – 2026, (US$ Million)
• Market Size and Forecast, By Indication, 2016 – 2026, (US$ Million)
• Market Size and Forecast, By Packaging Type, 2016 – 2026, (US$ Million)
• Market Size and Forecast, By Country/Region, 2016 – 2026, (US$ Million)
• Northern Africa
• Central Africa
• South Africa
8. Competitive Landscape
• Heat Map Analysis
• Company Profiles
• Analyst Views
9. Section
• References
• Research Methodology
• About us and Sales Contact

Other Related Reports:

Antifungal Drugs Market To Surpass US$ 16.2 Billion By 2028

Saudi Arabia Pharmaceutical Drugs Market To Surpass US$ 16,663.1 Million By 2027

Vitiligo Drug Market To Surpass US$ 348.3 Million By 2027

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837